Home › Funds › Royce & Associates › STAA
Royce & Associates position in STAA
STAAR SURGICAL CO · Health Care
Latest position (Q2 2023)18.62K sh
Reported value held$978.75K
Portfolio Weight0.01%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 55.25K | $7.10M | New |
| Q4 2021 | 55.25K | $5.04M | Hold |
| Q1 2022 | 55.95K | $4.47M | Add |
| Q2 2022 | 57.98K | $4.11M | Add |
| Q3 2022 | 57.25K | $4.04M | Reduce |
| Q4 2022 | 57.25K | $2.78K | Hold |
| Q1 2023 | 43.25K | $2.77K | Reduce |
| Q2 2023 | 18.62K | $978.75K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding STAA
- BlackRock Inc 6.73M sh · $193.12M · Q2 2026
- Vanguard Group 4.23M sh · $97.59M · Q4 2025
- Point72 Asset Management 2.44M sh · $69.93M · Q2 2026
- Goldman Sachs Group 2.15M sh · $61.71M · Q2 2026
- Morgan Stanley 1.32M sh · $37.76M · Q2 2026
- Geode Capital Management 1.08M sh · $30.88M · Q2 2026
- Charles Schwab Investment Management 445.71K sh · $12.79M · Q2 2026
- Northern Trust Corp 423.11K sh · $12.14M · Q2 2026
- Norges Bank Investment Management 365.20K sh · $10.48M · Q2 2026
- Renaissance Technologies 340.40K sh · $9.77M · Q2 2026
- Principal Global Investors 241.98K sh · $6.94M · Q2 2026
- BNY Mellon 229.28K sh · $6.58M · Q2 2026